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Evaluating biocompatibility is a core essential step to introducing a new material as
a candidate for brain-machine interfaces. Foreign body reactions often result in glial
scars that can impede the performance of the interface. Having a high conductivity and
large electrochemical window, graphene is a candidate material for electrical stimulation
with retinal prosthesis. In this study, non-functional devices consisting of chemical vapor
deposition (CVD) graphene embedded onto polyimide/SU-8 substrates were fabricated
for a biocompatibility study. The devices were implanted beneath the retina of blind
P23H rats. Implants were monitored by optical coherence tomography (OCT) and
eye fundus which indicated a high stability in vivo up to 3 months before histology
studies were done. Microglial reconstruction through confocal imaging illustrates that
the presence of graphene on polyimide reduced the number of microglial cells in the
retina compared to polyimide alone, thereby indicating a high biocompatibility. This study
highlights an interesting approach to assess material biocompatibility in a tissue model
of central nervous system, the retina, which is easily accessed optically and surgically.
Keywords: graphene, prosthesis, biocompatibility, retina, implant
INTRODUCTION
Brain machine interfaces are emerging technologies to restore perception and action following
different degenerative diseases and traumatic incidents (Slutzky, 2019). These interfaces can be
used directly on the brain or in more peripheral locations of the central nervous systems. In this
context, retinal prostheses have offered solutions to restore some useful vision in blind patients (da
Cruz et al., 2016; Stingl et al., 2017; Palanker et al., 2020). The targeted vision impairment is due
to retinitis pigmentosa and age-related macular degeneration that leads to the progressive loss of
photoreceptors in the retina. Though there exists no cure, rehabilitation therapy through electrical
stimulation at the retina has enabled late-stage patients to experience visual sensation including the
ability to read albeit with a low visual acuity (Hornig et al., 2017; Hahn and Fine, 2018). The Argus II
(Second Sight) (da Cruz et al., 2016) and the Alpha-AMS (Retina Implant AG) (Edwards et al., 2018)
devices have received approval for market sale to patients with end stage retinitis pigmentosa by
either the US FDA and European CE or only European CE, respectively. More recently, the Prima
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device was directly tested in patients with age-related macular
degeneration due to the expected high visual acuity (Lorach et al.,
2015; Palanker et al., 2020; Prévot et al., 2020). In all implant
designs, the devices contain an array of electrodes either in the
subretinal space (Alpha IMS, Prima) (Stingl et al., 2017; Palanker
et al., 2020) or in the epiretinal position in the vitreous body (da
Cruz et al., 2016). Electrical stimulation of the retina generates
phosphenes (visual sensation) to patients who learn over time to
associate them to form basic vision. However, current devices are
unable to provide facial recognition, independent locomotion,
and complex text reading. They require improvements to provide
restored vision of higher resolution.
For retinal prostheses, as for most brain machine interfaces,
conductive electrode materials with a high double layer
capacitance are expected to offer improved spatial resolution
(Joucla and Yvert, 2009). Carbon related materials and specifically
graphene and graphene derivatives are currently being studied
for their electrical properties as biosensors (Pumera et al.,
2010) and neural interfacing (Kostarelos et al., 2017). As
neural interfacing materials, graphene and their derivatives
make up a class of electrode material that have advantageous
properties for recording and stimulation. Graphene is a single-
layered, transparent but visible, 2-D material that has a large
electrochemical water window and high electron mobility (Ji
et al., 2014). Graphene is mainly grown at high temperatures on
metallic substrates such as copper in chemical vapor deposition
(CVD) reactors, and can be wet transferred onto flexible
polymer substrates (Lee et al., 2010). The high transparency
of CVD graphene has already been exploited in acute cortical
recordings simultaneously with calcium imaging (Kuzum et al.,
2014) as well as measuring electroretinograms in non-human
primates (Yin et al., 2018). Fabricating a 90% transparent
device with graphene electrodes has demonstrated its capability
to record brain signals during light dependent applications
such as florescence microscopy and optogenetics (Park et al.,
2014). For neural stimulation, flat CVD graphene is often
considered a poor material lacking the desired charge capacity
of metals. However, some have demonstrated its stimulation
capabilities to active cortical neurons (Park et al., 2018). In
addition, 3D nanostructures of graphene using porous templates
(Fan et al., 2013; Li et al., 2013), graphene foam (Dong
et al., 2012), and graphene mesh (Jiang and Fan, 2014) have
demonstrated to maintain graphene material properties with
increased electrochemical surface area for an improved charge
storage capacity that could be beneficial for neural stimulation.
Additionally, reduced graphene oxide generally made by redox
treatment of graphite have already been fabricated to include
porous structures intended for neural stimulation (Apollo et al.,
2015; Lu et al., 2016).
However, despite having ideal electrical properties, the safety
and biocompatibility of new materials must be evaluated before
determining their relevance in stimulation applications. A host
rejection to foreign material over time can render a device useless,
causing complications and requiring additional surgery. For
instances, gold electrodes were observed to have degraded within
a few months below the retina (Chow et al., 2001). Various studies
have provided evidence for the biocompatibility of graphene and
graphene derivatives to many cell types such as cultured human
and mouse fibroblast and various in vivo organs like rodent liver
and lung showing high cell viability and survival rates despite
some visual changes in histological results (Pinto et al., 2013).
Because tissue reactions can be very cell specific, there are few
studies evaluating the biocompatibility of graphene in the central
nervous system. It has been previously shown that single layer
graphene is capable of promoting an improved neurite growth
and adhesion for retinal ganglion neurons compared to glass
(Bendali et al., 2013) and that primary hippocampal neurons has a
significantly better adherence to graphene compared to insulating
polymers as well as CVD diamond in the absence of poly-L-
lysine (Bourrier et al., 2019). However, no in vivo study has been
completed to show a chronic biocompatibility of graphene in the
ocular environment.
In this study, the retina was used to investigate an
in vivo biocompatibility of graphene due its highly structured
organization in layers, which enables the identification of toxic
changes. The biocompatibility of graphene was examined in
the ocular environment of the P23H rat, a model of retinitis
pigmentosa. Soft and flexible subretinal implants with large
CVD graphene surfaces were designed and adapted to test
biocompatibility in rats. An in vivo monitoring of the implant
was taken to assess the retinal state and the implant stability in
the eye. Finally, a post mortem histological study was performed
to quantify microglial cells of the retina, which are an excellent
biomarker to monitor the reactive state (Polikov et al., 2005),
and thus the biocompatibility of graphene compared to a control
implant made of soft insulating polymers.
MATERIALS AND METHODS
Microfabrication of Device
Implants were designed to maximize the exposed area of
graphene on the circular head to the tissue with the underlying
metal contacts to validate the presence of graphene by a resistance
measurement (Figure 1). They were fabricated using a 4-inch
thermally oxidized Si wafer as a carrier support. A 10-µm
thick polyimide layer (PI-2611, HD MicroSystems) was spin-
coated and cured twice to obtain a substrate with a 20-µm
thickness. A lift-off process using image reversal photoresist
AZ5214 (Clariant GmbH, Germany) was used to define the metal
tracks (Ti/Pt, 10/100 nm) that were deposited using an electron-
beam vapor deposition system. Single layer graphene was grown
by CVD and transferred onto the polyimide substrate using a wet
chemical method as previously described (Blaschke et al., 2016;
Hébert et al., 2017). Large graphene areas (1 mm in diameter)
on top of the metal tracks were protected using a positive
photoresist (HiPR 6512, FujiFilm) that was used as a mask for
etching the rest of the graphene layer by means of an oxygen-
based reactive ion etching (RIE). After removing the photoresist,
the negative photoresist SU-8 (SU-8 2005, MicroChemCorp.,
United States) was spin-coated and defined to passivate the metal
leads while defining the uncovered graphene area. To define the
final geometry of the implants, a final photolithographic process
using a thick positive photoresist (AZ9260, Clariant) was used
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FIGURE 1 | Graphene-based implants. Orthogonal schemes of fabricated implants showing the side and top views. Graphene and platinum lines are passivated
between polyimide and SU-8. Control implants have the same scheme without the graphene layer, exposing instead the bottom polyimide layer.
to define the mask for structuring the 20-µm thick polyimide
layer in a deep-RIE process. The wafer was then cleaned in
isopropanol and rinsed with water before being peeled off from
the silicon wafer.
In parallel, a second wafer was processed to fabricate the
control devices. The process was identical as the one described
above but without the implementation of the graphene layer.
Subretinal Implantation
Twelve homozygous P23H rats were implanted with the
fabricated implant devices: N = 7 with graphene and N = 5
without graphene as a sham. Seven non-implanted eyes were
used for a retina-only control. Animals were enclosed in a
controlled environment with a half-day dark/light cycle with
nutrition ad libitum. All animal experiments were completed
in accordance to the Charles Darwin No5 Ethics Committee in
Animal Experimentation (agreement #15219) in the approved
animal facilities associated to the Institut de la Vision (Sorbonne
Université). All experimental work were performed according to
the institutional policies on biosecurity and safety procedures. All
animals were unilaterally implanted at 9-months of age. The short
surgery consisted of placing the device in the subretinal space in
the central region next to the optic nerve as previously described
(Salzmann et al., 2006). Briefly, anesthesia was provided by an
intraperitoneal injection of a ketamine-medetomidine mixture
(40 mg kg−1 ketamine, 0.14 mg kg−1 medetomidine) following
a 5% gaseous induction of isoflurane. An additional ocular
anesthesia using oxybuprocaïn chlorohydrate eye drops was
administered. Eye dilatation was obtained by application of
tropicamide (0.5%) solution. A heating platform maintained
body temperature at 37◦C. A small sclerotomy was performed
on the dorsal sclera tangential to the cornea. A gel of sodium
chondroitin sulfate – sodium hyaluronate (Viscoat Alcon) was
injected in the sclerotomy to generate a retinal detachment.
The implant was then inserted below the detached retina in
the subretinal space targeting an adjacent location to the optic
disk. Observation under the surgical microscope confirmed the
placement in the subretinal position using a plastic coverslip
gently pressed on ophthalmic gel that was applied to the cornea.
Subcutaneous injection of atipamezole (antisedan) was then used
to reanimate the animal in a chamber maintained 37◦C.
In vivo Monitoring
In vivo monitoring of implant state consisted of eye fundus and
optical coherence tomography (OCT) imaging done at 7, 15, 30,
60, and 90 days post implantation. Eye fundus images were taken
on a Micron III and Micron IV machines (Pheonix Technology
Group, Pleasanton, CA, United States) and OCT imaging was
done on a Bioptigen OCT system (Leica microsystems). Animal
anesthesia, eye dilation, and reanimation were performed in
the same manner as explained in the implantation section.
Immediately after the 90-day time point, the animals were
euthanized by CO2 induction followed by cervical dislocation.
Immunohistochemistry
Immediately after euthanasia, the implanted eye was removed
and dissected. The cornea and lens were removed in phosphate
buffer saline (PBS) solution (0.1 M, pH 7.4). A 3-mm biopsy
punch in the eye cup was used to extract the implant between the
retina and the sclera and choroid. This eye fragment was fixed by
incubation overnight in paraformaldehyde solution (4% in PBS)
at 4◦C and then washed using PBS.
For immunolabelling, eye fragments were incubated in a
blocking solution (10% bovine serum albumin (Sigma, France),
2% Triton X-100 (Sigma), 0.5% Tween 20 (Sigma, France)
and 0.1 g L−1 Thimerosal (Sigma, France) in PBS for 1 h at
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room temperature. Afterward, a 3-day incubation at 4◦C with
slow stirring was done, followed by an incubation at room
temperature for 2 h with primary antibodies in blocking solution.
The antibodies used were polyclonal antibodies directed against
Chicken anti Glial Fibrillary Acidic Protein (1:100, LifeSpan
Biosciences, WA, United States), Rabbit anti Iba1 (1:500, Wako
Sobioda, France). The fragments were rinsed and then incubated
with secondary antibodies: goat anti-Chicken IgY Alexa 647
and goat anti-rabbit IgG Alexa 488 (1:500, Molecular Probes,
Invitrogen, Eugene, OR, United States) for 2 days at 4◦C
followed by incubation at room temperature for 1 h. The nuclear
stain, 4′,6-diamidino-2-phenylindole (DAPI), was added to the
incubating solution prior to washing steps.
The implant/retina ensemble was then rinsed and mounted,
in permanent mounting medium (MM France, France), on
a microscope slide, for viewing under an upright confocal
microscope (FV1000, Olympus). DAPI counterstaining,
AlexaFluor-488, and AlexaFluor-647 were used to be detected by
excitation with a 405 nm laser diode, a 488 nm argon ion laser,
and 635 nm laser diode lines, respectively.
Microglial Count and Statistical Analysis
Confocal data was imported into Bitplane Imaris software for
visualization and analysis of microglial cells in the entire retina
using the Surface creation wizard. The Iba1 channel was selected
and surfaces were generated from the signal using a set threshold
to accurately visualize the source signal, which was then modeled
by the software. Cells were verified by colocalization using the
DAPI signal marking cell nuclei. False counts, duplicates as well
as cells overlapping the boarder of the image were filtered before
displaying the final result. Average cell volume was obtained by
dividing counted cells by the total area generated from the signal
source. Significance test was done using an unpaired two-tailed
Welch’s t-test utilizing a p < 0.05 significance level.
RESULTS
Microfabrication
The layer graphene grown for this study were characterized on
copper foil after the graphene growth and before their transfer
to the polymer substrate using SEM and Raman spectroscopy.
The SEM image (Figure 2a) shows that the graphene layer
is closed. Additionally some small second nucleation can be
distinguished every 50 µm. Figure 2b shows a representative
Raman spectrum of the layer graphene. Figures 2c,d are
mappings of 15 µm × 15 µm of the 2D/G ratio and 2D full
width at half maximum (FWHM). The G (around 1590 cm−1)
and 2D (around 2720 cm−1) bands of graphene can be clearly
observed while the By contrast, the D (around 1350 cm−1) band
cannot be distinguished suggesting that the layer has very few
defects (Ferrari, 2007). Furthermore, the value of 2D/G ratio of
around 4, and the 2D full width at half maximum (FWHM)
of around 25 cm−1 combined to the good homogeneity of this
characteristics over the mapped area. This provides proof of
a good crystalline quality single graphene layer (Ferrari, 2007;
Roscher et al., 2019) which has be shown to be an important
factor for neural affinity (Veliev et al., 2016). Using the metallic
tracks designed on the device extending up to the circular head
of the device, the successful transfer of graphene on this implant
head was verified by measuring the resistance between the tracks.
The resistance measured for all the implants was contained
between 0.5 and 1 kOhms instead of MOhms in the absence of
graphene indicating that the two tracks were indeed connected
by the deposited graphene.
Implantation and in vivo Monitoring
A total of 14 animals were used for this study. The animal
weighed an average 348 ± 15 g at the time of implantation and
393 ± 25 g at time of euthanasia 3 months later. To verify the
implant position, and in order to monitor any in vivo tissue
inflammation, the eye fundus and OCT image of an optical
retinal section was taken at specified intervals of 7, 15, 30, 60,
and 90 days. Figure 3 illustrates an example of the in vivo
monitoring by eye fundus and OCT scanning of an animal with
a graphene implant and an animal with a control polyimide
implant. It should be noted that eye fundus was taken during
a transition from the Micron III to the Micron IV machine
therefore displaying a transition in image results between day 60
and day 90 for the graphene images and between day 15 and day
30 for the polyimide control images. By eye fundus imaging, it
can be seen that the implant was placed dorsal to the optic nerve
and remained in the same location during the entire monitoring
period. Additionally, no apparent delamination of the graphene,
passivation layer, nor the metal contacts can be identified. The
implant was confirmed to be in the subretinal space visualized
by the large retinal vasculature above the implant, the white line
indicates the area where the OCT image was taken.
Optical coherence tomography imaging provided a second
confirmation of a subretinal implantation, showing that the
implant was placed between the choroid and the retina. OCT
images displayed in Figure 3 were averaged from five consecutive
frames of the OCT scan at the location of the eye indicated
by the white line in the eye fundus images. The OCT imaging
demonstrated that retinal reattachment had occurred at day 7
with no subsequent retinal detachment until the end of the
monitoring for both types of implants. Looking closely at the
implant/retina OCT images (bottom row of Figure 3), the retina
seems to be uniform and in close contact with the implant,
indicating no inflammation. Supplementary Figure 1 shows the
eye fundus and OCT scan of P23H rats at age of 9 and 12 months
that had no implantation.
Immunohistochemistry
After the in vivo monitoring, inflammation at the cellular level
was examined. The eye fragment containing the implant was fixed
and treated to visualize glial cells. Histological examinations of
the tissue indicated the well-preserved retina above the implant,
as it can be seen at a 10x magnification in Figure 4. An
immunolabelling was achieved to reveal the microglial cells (Iba1
antibody) and macroglial cells (GFAP antibody), while the DAPI
staining revealed all cell nuclei within the retinal tissue above the
implant. At the low magnification (10x), the implant could be
seen below the retina by the green polyimide autofluorescence
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FIGURE 2 | SEM and Raman spectroscopy of the single layer graphene (a) SEM of graphene on copper. The black arrows show the position of the second
nucleation, (b) representative Raman spectrum, no D band can be observed, (c) 2D/G mapping of a 15 µm × 15 µm area, (d) FWHM mapping of a
15 µm × 15 µm area.
when imaging at the bipolar cell layer of both types of devices
(Figure 4), and also when looking at the vertical retinal sections
(Figures 5i,j). On the same field of view, the GFAP-macroglial
cells were observed to remain at the surface of the retinal
tissue. In both types of implants (Figure 4), the classic dense
retinal network of astrocytes was visible at the low and high
magnifications. Iba1-immunopositive microglial cells (green in
Figure 4, 5) were seen in the tissue depth to form a more discrete
network of cells among other cells revealed by DAPI-stained
nuclei (blue in Figures 4, 5). The distribution of microglial cells
could be discretely defined inside the tissue depth by serial optical
confocal imaging allowing reconstruction of vertical sections
showing the different layers of DAPI-stained nuclei (Figure 5).
This cell type were observed in different horizontal levels within
the retinal tissue in the inner plexiform layer (IPL) below the
ganglion cell layer containing dispersed DAPI-stained nuclei
and in the outer plexiform layer (OPL) just below the implant.
The inner nuclear layer (INL) composed by dense DAPI-stained
nuclei was devoid of microglial cells as in the normal tissue.
Therefore, the microglial distribution appeared normal within
the depth of the retina with no abnormal accumulation at the
surface of the graphene implant direct contact.
Statistical Analysis of Inflammatory
Markers
To further quantify any potential retinal reactive state at
the graphene implant interface, the microglial cells above the
implants were counted. Figure 6a illustrates the strategy used
for quantifying microglial cells within the retinal volume with
a 0.1 mm2 base area. Using Iba1 data from confocal imaging,
microglial cells could be reconstituted within the investigated
volume for a semi-automated counting. Individual cells were
quantified for both graphene implants and control polyimide
implants. A quantification on non-operated P23H rat eyes at
the same age was also added for comparison to the degenerated
retina. This quantification showed that the number of microglial
cells within the retina was significantly greater in the presence
of the control polyimide implant (123.6 ± 21.1, n = 5) than in
the control non-operated eyes (67.0 ± 8.4, n = 7, p = 0.044).
This could be expected from the surgical stress and the implant
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FIGURE 3 | In vivo imaging of devices with graphene (top set) and devices without graphene (bottom set) at different specified time intervals. Each set includes
eye fundus (top row), OCT scans of device in the eye (middle row), and a magnified image of OCT scan showing only the retina and device (bottom row). Eye
fundus provides evidence for the long-term stability of both types of devices up to 90 days. The white line indicates the location where the OCT scans were taken.
The OCT scans shows the implant (red arrow) sandwiched between the retina (white arrow) and the choroid (yellow). Dotted white box is a zoom of each OCT scan
showing in detail the retina and device. The magnified images of the OCT scans (bottom row) show the close contact of the retina and implant devices. Bottom row
of each set is the zoom on the retina in contact with implant as indicated by dashed line of the OCT scan. All scale bars are 200 µm.
presence (Figure 6b). However, this difference was reduced
for implants consisting graphene (79.86 ± 8.8, n = 7) with
respect to the retina from non-operated eyes with no significant
difference between the two. All differences between the graphene
implant with either the polymer implants (p = 0.110) and the
control P23H retina (p = 0.131) were not statistically significant.
The results by microglial count signify that graphene is more
biocompatible than the polymer implant.
In pathological conditions, microglial cells are known to
change from a star-like shape with long processes indicating a
relaxed state to a more amoeboid morphology. This change in
state alters the cell body volume, which can be quantified through
the Iba1-immunolabeled microglial cells. In non-operated eyes,
the microglial cell volume (749.9 ± 118.8 µm3) was greater than
that measured for the graphene implant (556.2± 251.8 µm3) and
for the control polymer implants (554.8 ± 299.9 µm3). Though
there are no significant differences in microglial volume between
non-operated eye and operated eye (p < 0.5), the average volume
in the graphene implant and polymer implant is similar to each
other and smaller than non-operated tissue. The results signify
that graphene does not impact the biocompatibility of polyimide
and SU-8 polymers.
DISCUSSION
Graphene is a new carbon-based material with a large
water window providing exceptional electrical performances
for neurophysiological recording and capable charge injection
for neuronal stimulation. Despite this, free carbon-nanotubes
were found to present some toxicity issues (Yan et al., 2019).
Therefore, it is necessary to determine whether a carbon-
based electrode tethered to a device would present toxicity
to nervous tissue. Previous cell culture studies have already
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FIGURE 4 | Low (10x) and high (40x) magnifications of retinal tissues at the graphene and polyimide implant interface. Images show the different immunolabeled
cells: green Iba1-positive microglia, and white GFAP-positive Müller and astrocyte cells with blue DAPI-stained nuclei. Note the green autofluorescent polyimide ring
of the implants at the 10x magnification in the bipolar layer of the polyimide control and at both layer for the graphene implant. Scale bars are 50 µm (10x) and
200 µm (40x).
demonstrated the high biocompatibility of CVD graphene
bounded to a hard material (glass) for retinal neurons
(Bendali et al., 2013) as well as investigated its effect on
peripheral neurons (Convertino et al., 2018). Additionally,
CVD graphene coated onto intracortical probes that were
chronically implanted in mice cortex showed that that the
presences of graphene had reduced the local density of astrocytes
and microglia at the implanted site (Bourrier et al., 2019).
Following graphene transfer on soft biocompatible polymer
material, the in vivo biocompatibility of graphene in the
retina was shown here. The retina represents a relatively
accessible location to the central nervous system and could
bypass complication of placing materials directly on the brain.
These results are important for further use of graphene in
retinal prostheses for restoring vision. However, the results
have wider relevance for applications in any other part of the
central nervous system.
In the context of visual restoration, the study was performed
in the blind homozygous P23H rat, which is widely used as a
model of retinitis pigmentosa due to a complete degeneration of
photoreceptors occurring prior to 9 months (Pinilla et al., 2005;
Orhan et al., 2015). The 3 months in vivo follow-up showed
a high stability of the large area of graphene placed between
flexible polyimide and SU-8 substrate without any delamination.
Generally, retinal implant arrays contain microelectrodes (less
than 100 µm in diameter) for electrical stimulation. Here, a
worst-case scenario was assessed by using a 1 mm diameter
electrode, which represents the largest possible graphene-retinal
interface without increasing the dimensions of the device. The
graphene electrode was connected to two metal contacts used to
verify the presence of graphene. However, the lack of functional
electrode in these devices did not allow for the assessment
of tissue damage and inflammation that could result from
electrical stimulation.
Functional devices require a tail relayed to an external
headstage connector, which is not the case here. However, such
complete systems introduce an additional mechanical constraint
within a moving eye could lead to potential shear stress at the
electrode array which could result in an inflammation. Such
functional devices had been for instance produced with titanium–
platinum or diamond electrodes for monitoring the evolution
of electrode impedance over time (Linderholm et al., 2013;
Hébert et al., 2016). Eye fundus examination and OCT imaging
confirmed the absence of abnormal situations (edema and
hemorrhage, Linderholm et al., 2013) during the in vivo period.
This in vivo monitoring further demonstrated that graphene
remained in tight contact with the retinal tissue for the whole
implantation period.
Microglial cells act in the retina and more generally in
the central nervous system as resident macrophages assessing
cell function and any intrusion. Biocompatibility of various
materials could be investigated by assessing the reactive microglia
status as indicated by microglial proliferation and amoeboid
transformation into macrophages. In the degenerating retina,
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FIGURE 5 | Microglial distributions within the retinal tissues at the graphene (a–d,j) and control polymer interface (e–i). Confocal images of the retinal tissues
showing Iba1-positive microglia cells (green) at different depths. (a,e) Optic fiber layer showing GFAP-positive Müller and astrocyte cells (white) and no microglial
cells. Iba1-positive microglial cells with DAPI-stained nuclei (blue) at the junction between the inner plexiform layers (IPL) and the ganglion cell layer (GCL) (b,f), in the
inner nuclear layer (INL) (c,g) in the outer plexiform layer (OPL) (d,h). Confocal reconstruction of vertical sections for the retina above the control polymer implant (i)
and the graphene implant (j) showing the different depths (1–4) for all above horizontal sections (a–h). Scale bars represent 100 µm in (a–h) and 50 µm in (i,j).
FIGURE 6 | Modeling of microglia based on Iba1 marker on retinal tissue in contact with devices with graphene (a). Each different color represent a different
microglial. Scale bars are 50 µm. Graph (b) is the statistical analysis of microglial count comparing retinal tissue in contact with the two types of implant and retinal
tissue from non-operated eyes. Graph (c) is the comparison of microglial volume between the three conditions. ns indicates p > 0.05, * indicates p ≤ 0.05.
microglial cells are expected to be already in a reactive state.
We therefore decided to use the Iba1 marker to label both
reactive and relaxed microglial cells in the retina to visualize
the inflammatory response at the implant position. Assessing
cell volume gave an indication on morphology, which indirectly
relates to the active/non-reactive state of the tissue. Although
surgery and the presences of a retinal implant induced a change
in microglial features, microglial count in the retina in contact
with polymer implants was significantly greater than in non-
operated eyes. However, there was no significant difference
between that of graphene implants and non-operated eyes.
Additionally, average microglial volume showed no significant
differences between graphene and control implants made with
biocompatible polymers. In addition, there were no significant
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differences between both implant and non-operated eyes. These
findings are consistent with a high biocompatibility of graphene-
based electrodes as previously suggested with in vitro studies
(Bendali et al., 2013; Convertino et al., 2018), and in vivo studies
(Bourrier et al., 2019). However, future works should assess
neuronal function to demonstrate further the biocompatibility
of the graphene material although this assessment is particularly
difficult in blind animals with a flat electroretinogram (Pinilla
et al., 2005; Orhan et al., 2015).
CONCLUSION
Assessing in vivo material biocompatibility is an essential step
in developing new technologies for neuronal recording and
stimulation in electronic devices. This study focused on CVD
graphene material and its potential use in active electrodes. The
study demonstrates that the presences of graphene induces a
lesser inflammation quantified by microglial labeling compared
to biocompatible polymers. Graphene can therefore be further
investigated for use in electrodes for retinal prostheses or more
generally any electronic device for recording and stimulation
of the central nervous system. Further studies will assess more
developed graphene structures on chronic devices to compare
biocompatibility, safety and stimulation capabilities between
classic materials and graphene-based electrodes.
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